Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Piramal Pharma's dividends per share for the
three
months ended in Jun. 2026 was ₹0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0.14. Its Dividend Payout Ratio for the
three
months ended in Jun. 2026 was 0.00. As of today, Piramal Pharma's Dividend Yield % is 0.07%.
During the past 12 months, Piramal Pharma's average Dividends Per Share Growth Rate was 27.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Piramal Pharma (NSE:PPLPHARMA) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Piramal Pharma's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as
During the past 6 years, the highest Dividend Payout Ratio of Piramal Pharma was 0.12. The lowest was 0.12. And the median was 0.12.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 6 years, the highest Dividend Yield of Piramal Pharma was 0.10%. The lowest was 0.04%. And the median was 0.06%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piramal Pharma Dividends per Share Related Terms
Piramal Pharma Dividends per Share Historical Data
* Premium members only.
The historical data trend for Piramal Pharma's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:PPLPHARMA vs ZTS: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Piramal Pharma Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Piramal Pharma's Dividend Yield % falls into.
Piramal Pharma (NSE:PPLPHARMA) has a Dividends per Share of ₹0.14 as of Jun. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Piramal Pharma and its competitors.
Is Piramal Pharma's Dividends per Share too high?
Piramal Pharma's current Dividends per Share is ₹0.14. Overall, Piramal Pharma has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Piramal Pharma's Dividends per Share compare to ZTS?
Piramal Pharma's Dividends per Share of ₹0.14 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Piramal Pharma and its competitors. Piramal Pharma's current Dividends per Share is ₹0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piramal Pharma stock overvalued right now?
Based on GuruFocus' analysis, Piramal Pharma (NSE:PPLPHARMA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹176.52, compared to a current price of ₹195.68 — trading 10.9% above its estimated fair value. The current Dividends per Share is ₹0.14. Piramal Pharma's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Piramal Pharma (NSE:PPLPHARMA), the current Dividends per Share is ₹0.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Piramal Pharma (NSE:PPLPHARMA) Overvalued in 2026?
Based on GuruFocus' analysis, Piramal Pharma stock appears to be overvalued.
The current stock price of ₹195.68 is trading 10.9% above its estimated GF Value™ of ₹176.52.
GuruFocus considers Piramal Pharma to be Modestly Overvalued.
Key valuation signals for NSE:PPLPHARMA:
Dividends per Share: ₹0.14
GF Value™: ₹176.52 vs. price of ₹195.68 (10.9% above fair value)
No single metric tells the full story. See the NSE:PPLPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.
50GF Score
Get the complete analysis for NSE:PPLPHARMA
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PPLPHARMA has been successfully added to your 
